Dr. Farin Kamangar

Title: 
University Distinguished Professor and Associate Dean
Office Location: 
Dixon Research Center 200
Phone: 
(443) 885-4788
Email: 
Farin.Kamangar@morgan.edu
Education:

Ph.D. Epidemiology, Johns Hopkins University, 2005
M.H.S. Biostatistics, Johns Hopkins University, 2005
M.P.H. Tehran University of Medical Sciences, 2000
M.D. Tehran University of Medical Sciences, 1996

Education:

Ph.D. Epidemiology, Johns Hopkins University, 2005
M.H.S. Biostatistics, Johns Hopkins University, 2005
M.P.H. Tehran University of Medical Sciences, 2000
M.D. Tehran University of Medical Sciences, 1996

Research Interests:

Epidemiology of chronic diseases, with an emphasis on epidemiology of esophageal and gastric cancers. Other areas of interest are carcinogenicity of opium, polycyclic aromatic hydrocarbons, and hot beverages, as well as effects of opium use on cardiovascular diseases and other chronic conditions.

Dr. Kamangar has served as the PI or Co-PI of over $50 million of NIH-funded research projects, including the ASCEND Training Model to Increase Diversity in the Biomedical Research Workforce and the Golestan Cohort Study, a large cohort study of over 50,000 individuals with over 12 years of follow-up.

Selected Publications (Total: >200, Google Scholar H-Index 57, citations: >15,000):

  • Rahmati A, Shakeri R, Khademi H, Poustchi H, Pourshams A, Etemadi A, Khoshnia M, Sohrabpour AA, Aliasgari A, Jafari E, Islami F, Semnani S, Gharavi S, Abnet CC, Pharoah P, Brennan P, Boffetta P, Dawsey SM, Malekzadeh R, Kamangar F. Mortality from respiratory diseases associated with opium use – A population-based cohort study. Thorax 2017, 72:1028-1034.
  • Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: A risk factor for multiple cancers? Lancet Oncology 2014, 15: e69 - e77.
  • Karimi P, Islami F, Anandasbapathy S, Freedman ND, Kamangar F. Gastric Cancer: Descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiology, Biomakers, and Prevention 2014, 23: 700 - 713.
  • Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, Abaie B, Islami F, Nasseri-Moghaddam S, Byrnes G, Abnet CC, Dawsey SM, Ponder BA, Day NE, Pharoah PD, Boffetta P, Brennan P, Kamangar F. Opium use and mortality in the Golestan Cohort Study: A prospective study of 50,000 adults. BMJ 2012, 344: e2502.
  • Kamangar F, Schantz MM, Abnet CC, Fagundes RB, Dawsey SM. High levels of carcinogenic polycyclic aromatic hydrocarbons in maté drinks. Cancer Epidemiology, Biomarkers, and Prevention 2008, 17: 1262 - 1268.
  • Kamangar F, Dores GM, Anderson WF. Patterns of cancer, incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Journal of Clinical Oncology 2006, 24: 2137 - 2150.